What are the steps for managing Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diabetic Ketoacidosis: Step-by-Step Protocol

Begin with aggressive isotonic saline resuscitation at 15-20 mL/kg/hour for the first hour, followed by continuous IV insulin at 0.1 units/kg/hour once potassium is ≥3.3 mEq/L, and continue insulin until complete resolution of ketoacidosis regardless of glucose levels. 1, 2

Step 1: Initial Assessment and Diagnosis

Confirm DKA diagnosis when all three criteria are present: 1, 2

  • Blood glucose >250 mg/dL
  • Arterial pH <7.3
  • Serum bicarbonate <15 mEq/L with positive ketones

Obtain immediate laboratory studies: 3, 1

  • Plasma glucose, electrolytes with calculated anion gap, serum ketones
  • Blood urea nitrogen/creatinine, arterial blood gases
  • Complete blood count with differential, urinalysis, urine ketones
  • Electrocardiogram
  • HbA1c to determine if this represents poor chronic control or acute decompensation 3

Identify precipitating factors: 1, 2

  • Obtain bacterial cultures (blood, urine, throat) if infection suspected
  • Evaluate for myocardial infarction, stroke, pancreatitis, trauma
  • Review medications, particularly SGLT2 inhibitors
  • Assess for insulin omission or inadequacy

Step 2: Fluid Resuscitation (FIRST PRIORITY)

Hour 1 - Aggressive initial resuscitation: 3, 1, 2

  • Administer isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour (approximately 1-1.5 liters in average adult)
  • This restores intravascular volume, improves renal perfusion, and enhances insulin sensitivity

Subsequent fluid management (after hour 1): 3, 1

  • If corrected serum sodium is normal or elevated: use 0.45% NaCl at 4-14 mL/kg/hour
  • If corrected serum sodium is low: continue 0.9% NaCl at similar rate
  • Correct serum sodium for hyperglycemia: add 1.6 mEq to sodium value for each 100 mg/dL glucose above 100 mg/dL 3

When glucose reaches 250 mg/dL: 1, 4

  • Change fluid to 5% dextrose with 0.45-0.75% NaCl
  • This prevents hypoglycemia while continuing insulin to clear ketones
  • Critical pitfall: Failure to add dextrose at this threshold while continuing insulin is a common cause of hypoglycemia 1, 4

Step 3: Potassium Management (BEFORE INSULIN)

Check initial potassium level and act accordingly: 1, 2

  • If K+ <3.3 mEq/L: Hold insulin therapy completely and aggressively replace potassium until ≥3.3 mEq/L to prevent life-threatening arrhythmias and respiratory muscle weakness 1, 2

  • If K+ 3.3-5.5 mEq/L: Add 20-30 mEq potassium per liter of IV fluid (use 2/3 KCl and 1/3 KPO₄) once adequate urine output confirmed 3, 1

  • If K+ >5.5 mEq/L: Withhold potassium initially but monitor closely, as levels will drop rapidly with insulin therapy 1

Target serum potassium 4-5 mEq/L throughout treatment - hypokalemia occurs in approximately 50% of patients during treatment and is a leading cause of mortality in DKA. 1, 2

Step 4: Insulin Therapy

For moderate to severe DKA (critically ill, mentally obtunded): 1, 2

  • Start continuous IV regular insulin at 0.1 units/kg/hour
  • This is the standard of care for severe cases

For mild-to-moderate uncomplicated DKA: 1

  • Subcutaneous rapid-acting insulin analogs combined with aggressive fluid management are equally effective and potentially safer than IV insulin
  • More cost-effective option when appropriate

Monitor insulin response: 1

  • Target glucose decline of 50-75 mg/dL per hour
  • If glucose does not fall by 50 mg/dL in first hour, check hydration status; if acceptable, double insulin infusion rate hourly until steady decline achieved

Critical principle: Never stop insulin when glucose normalizes 1, 4

  • Continue insulin infusion until complete resolution of ketoacidosis
  • Target glucose 150-200 mg/dL until DKA resolved
  • Ketonemia takes longer to clear than hyperglycemia 4
  • Interruption of insulin when glucose falls is a common cause of persistent or worsening ketoacidosis 1, 4

Step 5: Monitoring During Treatment

Draw blood every 2-4 hours for: 1, 4

  • Serum electrolytes, glucose, blood urea nitrogen, creatinine
  • Osmolality and venous pH (adequate for monitoring; typically 0.03 units lower than arterial pH)
  • Anion gap to confirm ketoacid clearance

Preferred ketone monitoring: 1, 4

  • Direct measurement of β-hydroxybutyrate in blood is preferred
  • Nitroprusside method only measures acetoacetic acid and acetone, not β-hydroxybutyrate, and should not guide treatment response

Step 6: Bicarbonate Therapy (Generally NOT Recommended)

Do NOT administer bicarbonate if pH >6.9-7.0 1, 2

  • Studies show no difference in resolution time or outcomes
  • May worsen ketosis, cause hypokalemia, and increase cerebral edema risk
  • Only consider if pH <6.9 with severe acidosis

Step 7: Resolution Criteria

DKA is resolved when ALL of the following are met: 1, 4, 2

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Step 8: Transition to Subcutaneous Insulin

Timing is critical to prevent recurrence: 1, 2

  • Administer basal insulin (intermediate or long-acting) 2-4 hours BEFORE stopping IV insulin infusion
  • This overlap prevents recurrence of ketoacidosis and rebound hyperglycemia
  • Critical pitfall: Premature termination of IV insulin before basal insulin takes effect leads to DKA recurrence 1

If patient is NPO after DKA resolution: 4

  • Continue IV insulin and fluid replacement
  • Supplement with subcutaneous regular insulin every 4 hours as needed
  • Give 5-unit increments for every 50 mg/dL increase above 150 mg/dL (up to 20 units for glucose 300 mg/dL)

When patient can eat: 1, 4

  • Start multiple-dose regimen combining short/rapid-acting and intermediate/long-acting insulin
  • Continue IV insulin for 1-2 hours after starting subcutaneous insulin to ensure adequate plasma levels

Special Considerations and Pitfalls

SGLT2 inhibitor-associated DKA: 1, 2, 5

  • Discontinue SGLT2 inhibitors 3-4 days before any planned surgery
  • Monitor for euglycemic DKA (normal or mildly elevated glucose with ketoacidosis)
  • If euglycemic DKA present, start D5 alongside 0.9% NaCl at beginning of insulin treatment 4

Common causes of treatment failure: 1, 4

  • Inadequate potassium monitoring and replacement
  • Interruption of insulin infusion when glucose normalizes
  • Failure to add dextrose when glucose falls below 250 mg/dL
  • Overzealous insulin without glucose supplementation leading to hypoglycemia
  • Not treating underlying precipitating cause (infection, MI, medication issues)

Total body deficits to replace over 24 hours: 3

  • Water: 6 liters in DKA
  • Sodium: 7-10 mEq/kg
  • Potassium: 3-5 mEq/kg
  • Chloride: 3-5 mEq/kg

References

Guideline

Assessment and Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of diabetic ketoacidosis in special populations.

Diabetes research and clinical practice, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.